Metabolic reprogramming: A novel therapeutic target in diabetic kidney disease
Mengdi Wang(Zhengzhou University), Wenjing Zhao(Capital Medical University), Cun Shen(Capital Medical University), Yufei Liu(Capital Medical University), Zhen Cai(First Affiliated Hospital Zhejiang University), Lei Tian(Capital Medical University), Yuan Meng(Capital Medical University), Mengchao Liu(Capital Medical University), Yifan Guo(Capital University), Yanyu Pang(Capital Medical University)
Cited by 41
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Clinical Utility of In-house Metagenomic Next-generation Sequencing for the Diagnosis of Lower Respiratory Tract Infections and Analysis of the Host Immune Response
|Clinical Infectious Diseases|2020|195
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections
|Clinical Chemistry|2021|130
Enhancing lower respiratory tract infection diagnosis: implementation and clinical assessment of multiplex PCR-based and hybrid capture-based targeted next-generation sequencing
|EBioMedicine|2024|122
Age-related changes in the mitochondria of human mural granulosa cells
|Human Reproduction|2017|78